Your browser doesn't support javascript.
loading
Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2- early breast cancer: results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2- trial.
Gluz, O; Kuemmel, S; Nitz, U; Braun, M; Lüdtke-Heckenkamp, K; von Schumann, R; Darsow, M; Forstbauer, H; Potenberg, J; Uleer, C; Grischke, E M; Aktas, B; Schumacher, C; Zu Eulenburg, C; Kates, R; Józwiak, K; Graeser, M; Wuerstlein, R; Baehner, R; Christgen, M; Kreipe, H H; Harbeck, N.
  • Gluz O; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach; University Clinics Cologne, Cologne. Electronic address: oleg.gluz@wsg-online.com.
  • Kuemmel S; West German Study Group, Moenchengladbach; Breast Unit, Kliniken Essen-Mitte, Essen; Department of Gynecology with Breast Center, Charité - Universitätsmedizin Berlin, Berlin.
  • Nitz U; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach.
  • Braun M; Breast Center, Rotkreuz Clinics Munich, Munich.
  • Lüdtke-Heckenkamp K; Department of Oncology and Hematology, Niels Stensen-Kliniken, Georgsmarienhütte.
  • von Schumann R; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach.
  • Darsow M; Breast Center, Luisenhospital, Duesseldorf; Practice for Senologic Oncology, Duesseldorf.
  • Forstbauer H; Oncology Practice Network Troisdorf, Troisdorf.
  • Potenberg J; Ev. Waldkrankenhaus Berlin, Berlin.
  • Uleer C; Frauenaerzte am Bahnhofsplatz, Practice of Gynecology and Oncology, Hildesheim.
  • Grischke EM; Women's Clinic, University Clinics Tuebingen, Tuebingen.
  • Aktas B; Women's Clinic, University Clinics Essen, Essen; University Clinics Leipzig, Women's Clinic, Leipzig.
  • Schumacher C; Breast Center, St. Elisabeth Hospital Cologne, Cologne.
  • Zu Eulenburg C; West German Study Group, Moenchengladbach; Department of Medical Biometry and Epidemiology, University Medical Center Hamburg, Hamburg.
  • Kates R; West German Study Group, Moenchengladbach.
  • Józwiak K; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin.
  • Graeser M; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach; Department of Gynecology, University Medical Center Hamburg, Hamburg.
  • Wuerstlein R; West German Study Group, Moenchengladbach; Breast Center, Department of Gynecology and Obstetrics and CCC Munich, LMU University Hospital, Munich, Germany.
  • Baehner R; Exact Sciences, Redwood City, USA.
  • Christgen M; Institute of Pathology, Medical School Hannover, Hannover, Germany.
  • Kreipe HH; Institute of Pathology, Medical School Hannover, Hannover, Germany.
  • Harbeck N; West German Study Group, Moenchengladbach; Breast Center, Department of Gynecology and Obstetrics and CCC Munich, LMU University Hospital, Munich, Germany.
Ann Oncol ; 34(6): 531-542, 2023 06.
Article en En | MEDLINE | ID: mdl-37062416
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article